These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17323365)

  • 1. Different methods of creatinine measurement significantly affect MELD scores.
    Cholongitas E; Marelli L; Kerry A; Senzolo M; Goodier DW; Nair D; Thomas M; Patch D; Burroughs AK
    Liver Transpl; 2007 Apr; 13(4):523-9. PubMed ID: 17323365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interlaboratory variability in assessment of the model of end-stage liver disease score.
    Lisman T; van Leeuwen Y; Adelmeijer J; Pereboom IT; Haagsma EB; van den Berg AP; Porte RJ
    Liver Int; 2008 Dec; 28(10):1344-51. PubMed ID: 18482269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the corrected-creatinine model for end-stage liver disease a feasible strategy to adjust gender difference in organ allocation for liver transplantation?
    Huo SC; Huo TI; Lin HC; Chi CW; Lee PC; Tseng FW; Lee SD
    Transplantation; 2007 Dec; 84(11):1406-12. PubMed ID: 18091516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation.
    Trotter JF; Brimhall B; Arjal R; Phillips C
    Liver Transpl; 2004 Aug; 10(8):995-1000. PubMed ID: 15390325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory test variability and model for end-stage liver disease score calculation: effect on liver allocation and proposal for adjustment.
    Ravaioli M; Masetti M; Ridolfi L; Capelli M; Grazi GL; Venturoli N; Di Benedetto F; Bianchi FB; Cavrini G; Faenza S; Begliomini B; Pinna AD; Gerunda GE; Ballardini G
    Transplantation; 2007 Apr; 83(7):919-24. PubMed ID: 17460563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel prognostic model based on serum levels of total bilirubin and creatinine early after liver transplantation.
    Xu X; Ling Q; Wu J; Chen J; Gao F; Feng XN; Zheng SS
    Liver Int; 2007 Aug; 27(6):816-24. PubMed ID: 17617125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of MELD score during the year before liver transplantation.
    Oton-Nieto E; Barcena-Marugan R; Carrera-Alonso E; Blesa-Radigales C; Garcia-Gonzalez M; Nuño J; Plaza-Palacios G; Garcia-Plaza A
    Transplant Proc; 2005 Nov; 37(9):3887-8. PubMed ID: 16386573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics.
    Weismüller TJ; Negm A; Becker T; Barg-Hock H; Klempnauer J; Manns MP; Strassburg CP
    Transpl Int; 2009 Oct; 22(10):970-8. PubMed ID: 19619170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MELD score and blood product requirements during liver transplantation: no link.
    Massicotte L; Beaulieu D; Roy JD; Marleau D; Vandenbroucke F; Dagenais M; Lapointe R; Roy A
    Transplantation; 2009 Jun; 87(11):1689-94. PubMed ID: 19502961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area.
    Xiol X; Gines P; Castells L; Twose J; Ribalta A; Fuentes-Arderiu X; Rodriguez S; Castellote J; Navasa M; Deulofeu R
    Liver Transpl; 2009 Mar; 15(3):300-5. PubMed ID: 19242993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MELD [corrected] score in patients accepted for liver transplantation 1994 to 2004.
    Flodén A; Castedal M; Friman S; Olausson M; Backman L
    Transplant Proc; 2006 Oct; 38(8):2673-4. PubMed ID: 17098035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores.
    Xia VW; Du B; Braunfeld M; Neelakanta G; Hu KQ; Nourmand H; Levin P; Enriquez R; Hiatt JR; Ghobrial RM; Farmer DG; Busuttil RW; Steadman RH
    Liver Transpl; 2006 Apr; 12(4):614-20. PubMed ID: 16555319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
    Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
    J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluids administration and coagulation characteristics in patients with different model for end-stage liver disease scores undergoing orthotopic liver transplantation.
    Li M; Zhang LP; Yang L
    Chin Med J (Engl); 2007 Nov; 120(22):1963-8. PubMed ID: 18067779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of liver transplantation outcome in patients with MELD Score > or = 30.
    Ferraz-Neto BH; Zurstrassen MP; Hidalgo R; Meira-Filho SP; Rezende MB; Paes AT; Afonso RC
    Transplant Proc; 2008 Apr; 40(3):797-9. PubMed ID: 18455020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical value of the model for end-stage liver disease score in predicting the prognosis of liver transplantation in patients with end-stage liver disease].
    Sun J; Guo ZH; Lai TS; Tang YQ; Su L; Huo F; Wang SP; Pu MS; Wen Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1731-2, 1742. PubMed ID: 18819907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the result of 409 cases with liver cirrhosis and severe hepatitis by using the model for end-stage liver disease].
    Song CH; Chen LM; Zhang LX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):168-70. PubMed ID: 17653326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores--a systematic bias.
    Cholongitas E; Marelli L; Kerry A; Goodier DW; Nair D; Thomas M; Patch D; Burroughs AK
    Am J Transplant; 2007 Mar; 7(3):685-92. PubMed ID: 17217437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.